BIOVIA launches Biologics Informatics Program

BIOVIA, the life sciences-oriented subsidiary of Dassault Systèmes formerly known as Accelrys, introduced a new informatics platform for companies developing biologic drugs, in an announcement at the Molecular Medicine Tri Conference in San Francisco.

 

BIOVIA CEO Max Carnecchia spoke to Bio-IT World correspondent Aaron Krol about the challenges to working with this rapidly growing class of therapies, and the need for IT programs tailored to the needs of biologics.

Click here to read the interview in full

Looking for something specific?